Will drugs someday reverse CAD? Three recent advances bring the possibility closer to reality.
D016632:Apolipoprotein A-I / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy*; D005464:Fluorobenzenes / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012074:Remission Induction / Q000379:methods; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use
D016632:Apolipoprotein A-I; D005464:Fluorobenzenes; D000960:Hypolipidemic Agents; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium